Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Mulder

Showing results (121-130 of 369) with videos related to

Pageof 37
Sort By:
Chest|November 1, 1991
Limitations of the fast green assay for chemosensitivity testing in human lung cancerE F Smit, E G de Vries, C Meijer, et al.
British Journal of Cancer|July 1, 1990
The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell lineC Meijer, N H Mulder, G A Hospers, et al.
European Journal of Nuclear Medicine|January 1, 1983
The significance of the aminoterminal propeptide of type III procollagen in paroxysmal nocturnal haemoglobinuria and myelofibrosisE Vellenga, N H Mulder, A K van Zanten, et al.
Lancet (London, England)|February 29, 1992
Infection after subcutaneous interleukin-2J Buter, E G de Vries, D T Sleijfer, et al.
International Journal of Cancer|October 21, 1991
Combined in vitro modulation of adriamycin resistanceC Meijer, N H Mulder, H Timmer-Bosscha, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1986
Bone marrow toxicity of cyclophosphazenes is related to their structure and the treatment scheduleN H Mulder, E G de Vries, H Timmer-Bosscha, et al.
British Journal of Cancer|March 1, 1989
Phase I study of 21 days continuous infusion with vindesineE G de Vries, E F Smit, D E Vendrig, et al.
British Journal of Cancer|February 1, 1992
Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanomaN H Mulder, E G de Vries, D T Sleijfer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
A phase II study of carboplatin and vincristine in previously treated patients with small-cell lung cancerE F Smit, H H Berendsen, E G de Vries, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 30, 1999
Combined cytotoxic effects of tumor necrosis factor-alpha with various cytotoxic agents in tumor cell lines that are drug resistant due to mutated p53S Sleijfer, T K Le, S de Jong, et al.
Pageof 37

Showing results (121-130 of 369) with videos related to

Sort By:
Pageof 37
Chest|November 1, 1991
Limitations of the fast green assay for chemosensitivity testing in human lung cancerE F Smit, E G de Vries, C Meijer, et al.
British Journal of Cancer|July 1, 1990
The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell lineC Meijer, N H Mulder, G A Hospers, et al.
European Journal of Nuclear Medicine|January 1, 1983
The significance of the aminoterminal propeptide of type III procollagen in paroxysmal nocturnal haemoglobinuria and myelofibrosisE Vellenga, N H Mulder, A K van Zanten, et al.
Lancet (London, England)|February 29, 1992
Infection after subcutaneous interleukin-2J Buter, E G de Vries, D T Sleijfer, et al.
International Journal of Cancer|October 21, 1991
Combined in vitro modulation of adriamycin resistanceC Meijer, N H Mulder, H Timmer-Bosscha, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1986
Bone marrow toxicity of cyclophosphazenes is related to their structure and the treatment scheduleN H Mulder, E G de Vries, H Timmer-Bosscha, et al.
British Journal of Cancer|March 1, 1989
Phase I study of 21 days continuous infusion with vindesineE G de Vries, E F Smit, D E Vendrig, et al.
British Journal of Cancer|February 1, 1992
Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanomaN H Mulder, E G de Vries, D T Sleijfer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
A phase II study of carboplatin and vincristine in previously treated patients with small-cell lung cancerE F Smit, H H Berendsen, E G de Vries, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 30, 1999
Combined cytotoxic effects of tumor necrosis factor-alpha with various cytotoxic agents in tumor cell lines that are drug resistant due to mutated p53S Sleijfer, T K Le, S de Jong, et al.
Pageof 37